Bad Drug Lawyers in Jackson MS
Onglyza / Kombiglyze XR – Linked to Heart Failure
We have highlighted a number of bad drugs before, and today is no different. During a recent meeting in St. Louis, we discussed Onglyza with a number of attorneys who, like us, work to keep their clients safe and expose misleading marketing tactics by drug companies.
Onglyza is a type 2 diabetes drug manufactured jointly by AstraZeneca and Bristol-Myers Squibb. It was approved by the FDA in 2009 and regulates insulin levels that your body produces after eating.
In 2011, it became the top selling drug with more than $700 million in sales. A 2013 study showed that medications that act in a similar fashion to Onglyza may be linked to a higher than normal risk of pancreatic cancer. In 2015, the FDA required AstraZeneca to place a warning on the Onglyza labels cautioning patients of a possible increased risk of heart failure.
The FDA decision came after reviewing data from the SAVOR study, which involved 16,492 patients; 1,222 of whom reported a major cardiovascular event. Of the 15 panelists, 14 voted in favor of placing a warning on the Onglyza labels, while one panel member voted to withdraw Onglyza from the U.S. market altogether.
Injuries: If you, or someone you know, experienced heart failure, cardiac failure, congestive heart failure, pancreatic cancer and/or death while on Onglyza or Kombiglyze XR, please call us. We have recently seen a higher number of heart failure and pancreatic cancer cases in Mississippi, likely due to a higher than average percentage of the population having diabetes and taking drugs like Onglyza or Kombiglyze XR.
If you have any questions, please contact the experienced bad drug attorneys at ‘Maggio|Thompson at 601-300-3333 .